Filing Details

Accession Number:
0001140361-16-082595
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-10-12 16:26:38
Reporting Period:
2016-10-11
Filing Date:
2016-10-12
Accepted Time:
2016-10-12 16:26:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1527599 Mirna Therapeutics Inc. MRIN Pharmaceutical Preparations (2834) 261824804
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1652055 Jon Irvin C/O Mirna Therapeutics, Inc.
2150 Woodward St., Suite 100
Austin TX 78744
Vice President, Finance No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-10-11 150 $1.83 8,335 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 29,2016.